Ledyard National Bank Incyte Corp Transaction History

Ledyard National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 12, 2019	SELL	$63.56 - $88.17 $79,577 - $110,388	-1,252 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$58.5 - $69.94 $73,242 - $87,564	1,252 New	1,252 $80,000
Q4 2017 Jan 30, 2018	SELL	$93.56 - $116.6 $1,496 - $1,865	-16 Closed	0 $0
Q3 2017 Oct 10, 2017	BUY	$109.15 - $138.27 $1,746 - $2,212	16	16 $2,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

Stay updated on Ledyard National Bank with notifications on news.